Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus.

Junpeng YangDongni ZhaoYi ChenYuehua MaXiaoyang ShiXiaobing WangYinghua LvHuijuan Yuan

Published in: Journal of diabetes investigation (2021)

Serum CTRP9 levels were independently associated with definite CAN. CTRP9 represents a reliable biomarker for exploring CAN in patients with type 2 diabetes mellitus.

Keyphrases

heart rate variability
left ventricular
heart rate
heart failure
blood pressure
atrial fibrillation